Roberta Pachera, MBA
VP CDMO Small Molecules & Global Key Accounts at Olon- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
Experience
-
Olon
-
Italy
-
Chemical Manufacturing
-
700 & Above Employee
-
VP CDMO Small Molecules & Global Key Accounts
-
Sep 2022 - Present
-
-
-
PharmaZell Group
-
Germany
-
Pharmaceutical Manufacturing
-
1 - 100 Employee
-
VP, Global Head of Custom Synthesis
-
Sep 2021 - Sep 2022
-
-
-
-
Director Contract Manufacturing Europe
-
Oct 2015 - Sep 2021
-
-
-
FIS-Fabbrica Italiana Sintetici S.p.A.
-
Vicenza Area, Italy
-
Area Manager,Europe
-
Nov 2014 - Sep 2021
-
-
-
Aptuit
-
Italy
-
Pharmaceutical Manufacturing
-
500 - 600 Employee
-
-
Jan 2014 - Sep 2021
-
-
-
Jan 2014 - Sep 2021
-
-
-
Dec 2010 - Jan 2014
Determine and implement the commercial strategy for assigned customers and territories. Actively position Aptuit to win a significant proportion of outsourced global projects from assigned customer(s) and territories across the following Aptuit service lines: API, PDM, Drug Discovery and Lead Optimization including Preclinical Biosciences and Clinical Sciences .Aggressively pursue awareness of competitive activities., positioning and pricing, which includes specific reasons for awards and non-awards for assigned customers Show less
-
-
-
GSK
-
United Kingdom
-
Pharmaceutical Manufacturing
-
700 & Above Employee
-
-
Nov 1996 - Jul 2010
Manager of Synthetic Chemistry, Safety and Quality for the department. Coordinate the research goals and objectives for the staff providing leadership and direction in achieving these goals and objectives. Project leader with groups based both in UK, US, and Italy. Responsible of conducting appropriate strategy for the development of drugs including projection of budget and resources. Project lead for the successful file and WW launch of Ambrisentan (Volibris): preparation of CMC regulatory dossier for US,EU and Japan filing, managing 3rd party contract manufacturer to ensure successful validation, development of scientific understanding to successfully respond to regulatory inquiries, management of a cross-functional team including chemistry, analytical, engineering, quality, and regulatory. Responsible on behalf of the WW GSK Chemical Development Department of the technical needs of the Drug Discovery Organization for Neglected Diseases based in Spain (Madrid).Experienced in the Due Diligence process Show less
-
-
-
Mar 2006 - Jun 2008
Team Manager with distinguished career in chemical research and R&D project management with proven track record of project delivery from early phase development to registration and launch. Impressive breadth of experience in leading early phase projects in different therapeutic area. Strong leadership skills demonstrated by managing multidisciplinary, global in the Italy, the UK, and US. A deep understanding of the Chemical and PreClinical Development global business acquired while on a long term global assignment in US (Mar2006-Jun2008) and a short term assignment in UK (Jun-Oct 98). Demonstrated ability to drive changes and implementing new way of working within the organization. Show less
-
-
Education
-
CUOA Business School
MBA -
School of Management, University of Michigan - Dearborn
marketing -
Alma Mater Studiorum – Università di Bologna
chemistry, organic chemistry